FIRST MERCANTILE TRUST CO - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 246 filers reported holding HAEMONETICS CORP in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
FIRST MERCANTILE TRUST CO ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2021$86,000
+3.6%
1,222
-1.5%
0.01%
+10.0%
Q2 2021$83,000
-33.6%
1,241
-1.0%
0.01%
-44.4%
Q1 2020$125,000
-33.5%
1,253
-23.4%
0.02%
-18.2%
Q4 2019$188,000
+1.6%
1,636
+11.7%
0.02%
+10.0%
Q3 2019$185,000
+5.1%
1,4640.0%0.02%
+5.3%
Q2 2019$176,000
-59.0%
1,464
-65.9%
0.02%
-81.7%
Q4 2018$429,000
-43.7%
4,287
-35.5%
0.10%
-30.7%
Q3 2018$762,000
+28.5%
6,651
+0.5%
0.15%
+27.1%
Q2 2018$593,000
+71.4%
6,617
+40.0%
0.12%
+63.9%
Q1 2018$346,000
+38.4%
4,728
+10.0%
0.07%
+46.9%
Q4 2017$250,000
-39.9%
4,298
-53.6%
0.05%
-34.7%
Q3 2017$416,000
+11.8%
9,268
-1.7%
0.08%
+11.9%
Q2 2017$372,000
-46.7%
9,424
-45.2%
0.07%
-36.8%
Q1 2017$698,000
-0.6%
17,200
-1.5%
0.11%
-2.8%
Q4 2016$702,000
+145.5%
17,460
+121.0%
0.11%
+186.8%
Q3 2016$286,000
-25.3%
7,900
-40.2%
0.04%
-20.8%
Q2 2016$383,000
+23.5%
13,200
+49.2%
0.05%
+26.3%
Q1 2016$310,000
-40.5%
8,850
-45.2%
0.04%
-28.3%
Q4 2015$521,000
-42.3%
16,150
-42.2%
0.05%
-41.8%
Q3 2015$903,000
-24.4%
27,950
-3.3%
0.09%
-10.8%
Q2 2015$1,195,000
+2072.7%
28,907
+1620.7%
0.10%
+2450.0%
Q1 2014$55,000
-92.9%
1,680
-90.9%
0.00%
-93.4%
Q4 2013$775,000
+4.3%
18,393
-1.2%
0.06%
+1.7%
Q3 2013$743,000
+9.9%
18,619
+14.0%
0.06%
+3.4%
Q2 2013$676,00016,3390.06%
Other shareholders
HAEMONETICS CORP shareholders Q3 2021
NameSharesValueWeighting ↓
Millrace Asset Group, Inc. 19,264$1,7262.13%
Parkman Healthcare Partners LLC 88,962$7,969,2161.46%
HEARTLAND ADVISORS INC 256,414$24,435,2741.37%
Riverwater Partners LLC 15,553$1,393,2381.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 111,100$9,952,3381.15%
Lisanti Capital Growth, LLC 78,425$7,025,3121.11%
Aristotle Capital Boston, LLC 311,666$27,919,0540.90%
ROYCE & ASSOCIATES LP 947,550$84,881,5290.86%
CHASE INVESTMENT COUNSEL CORP 18,770$1,6810.84%
Virtus Investment Advisers, Inc. 13,662$1,223,8420.83%
View complete list of HAEMONETICS CORP shareholders